Tous Actualités
Suivre
Abonner Prionics AG

Prionics AG

Animal Pharm Industry Awards assigned in London: Prionics nominated as a best in class Animal Health Company

Zurich (ots)

Prionics, the world leader in BSE and prion
testing, has been recognized for its contribution to animal health
and food safety. After being awarded with the European Biotech Award
2004, the nomination for the Animal Pharm Industry Awards honors the
achievements of the Swiss biotech company in successfully expanding
its solution portfolio for the early diagnosis of major farm animal
diseases. Today, Prionics ranks among the top three global companies
in farm animal diagnostics.
The first Animal Pharm Industry Excellence Awards
(www.animalpharmawards.com) held in London on October 12, 2006, has
identified best in class companies across the animal health
industries. The prize honors outstanding achievements, judging
innovation, performance, product pipeline, new drug launches and
financial return. "Being considered to be among the three best in
class animal health companies of the world and ranking on a level
with renowned companies such as Pfizer Animal Health is a tremendous
honour for Prionics. It confirms that our strategy to focus on major
farm animal health issues and grow our diagnostic portfolio
accordingly is working and that our solutions deliver a competitive
edge in the market", says Dr Markus Moser, CEO of Prionics.
Prionics Among Top 3 Global Players
Food safety by eliminating diseases early in the food chain is
growing in importance and market potential as it directly affects
disease prevention in human health management. Within ten years of
being formed, Prionics ranks among the three leading global
diagnostic players in farm animal health. The Swiss biotech company
intends to further develop its core business by creating diagnostic
solutions in its own R&D facilities and laboratories in Zurich as
well as through collaborations and acquisitions.
Building on an extensive scientific network with leading research
institutes around the world, earlier this year Prionics acquired CEDI
Diagnostics B.V. and signed a strategic partnership with the Animal
Science Group of Wageningen (Netherlands), a recognized leader in
animal disease control. With these latest moves the company has
further expanded its portfolio with tests proven on the market and
gained access to a unique research and competence centre.
About Prionics
Prionics is the world leader in the diagnosis of BSE and other
prion diseases. Founded in 1997 as a spin-off from Zurich University
and headquartered in Zurich, Prionics develops and markets diagnostic
products for the early diagnosis of farm animal diseases. The company
places its main focus on diseases which are transmissible from
animals to human beings and thereby contributing to an improvement to
food safety. In October 2005 Prionics acquired Pfizer Animal Health's
Diagnostic portfolio. The recipient of the Swiss Economic Award 2002
as "Company of the year" and winner of the European Biotech Award
2004 for Excellence in Biotech Business; Prionics is driving its
business through a combination of outstanding research, high-quality
products and innovative market solutions.

Contact:

Markus Abt
Head of Corporate Communications
Phone +41/44/200'20'95
Mobile +41/79/352'53'16
E-Mail: media@prionics.com
Internet: http:// www.prionics.com/media

Plus de actualités: Prionics AG
Plus de actualités: Prionics AG